SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-20-268550
Filing Date
2020-10-13
Accepted
2020-10-13 16:44:03
Documents
15
Period of Report
2020-07-28
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d33045d8ka.htm   iXBRL 8-K/A 27617
2 EX-23.1 d33045dex231.htm EX-23.1 1579
3 EX-99.2 d33045dex992.htm EX-99.2 178131
4 EX-99.3 d33045dex993.htm EX-99.3 143676
  Complete submission text file 0001193125-20-268550.txt   504082

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ljpc-20200728.xsd EX-101.SCH 2701
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ljpc-20200728_lab.xml EX-101.LAB 17365
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ljpc-20200728_pre.xml EX-101.PRE 10910
8 EXTRACTED XBRL INSTANCE DOCUMENT d33045d8ka_htm.xml XML 3356
Mailing Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121
Business Address 4550 TOWNE CENTRE COURT SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36282 | Film No.: 201236845
SIC: 2836 Biological Products, (No Diagnostic Substances)